Home > Introducing the National Drug Early Warning System.

Artigiani, Eleanor Erin and Wish, Eric D (2020) Introducing the National Drug Early Warning System. Current Opinion in Psychiatry, 33, (4), pp. 319-325. doi: 10.1097/YCO.0000000000000610.

External website: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC73864...

PURPOSE OF REVIEW: In 2013, NIH NIDA released a special funding opportunity to update and expand their longstanding Community Epidemiology Workgroup (CEWG) by creating a coordinating center for a new type of monitoring system that became the National Drug Early Warning System (NDEWS). This article provides an overview of four primary NDEWS components: core staff; an approach to detecting and monitoring emerging drug trends including community-based epidemiologists and national databases; small rapid follow-up studies; and innovative multimedia approaches for disseminating information.

RECENT FINDINGS: The cornerstones for detecting and monitoring are the 1700+ member NDEWS Network and a coalition of local epidemiologists. Follow-up studies are designed with local researchers, practitioners, and policymakers to focus on local trends. Among NDEWS accomplishments are developing protocols for expanded urinalyses in high-risk populations and conducting follow-up studies with local collaborators in New Hampshire, New York, Ohio, Oregon, and a tribal nation in Minnesota.

SUMMARY: During its first 6 years, NDEWS has advanced its mission to develop multidisciplinary collaborations and innovative technologies for identifying, monitoring, and following up on emerging drug trends and has contributed to the translation of science into practice.

Item Type
Publication Type
International, Open Access, Article
Drug Type
New psychoactive substance
Intervention Type
Harm reduction, Screening / Assessment
July 2020
Identification #
doi: 10.1097/YCO.0000000000000610
Page Range
pp. 319-325
Lippincott Williams & Wilkins

Repository Staff Only: item control page